首页> 外文学位 >RGS2 is a novel mediator of hypoxia-induced pulmonary artery constriction.
【24h】

RGS2 is a novel mediator of hypoxia-induced pulmonary artery constriction.

机译:RGS2是缺氧诱导的肺动脉收缩的新型介体。

获取原文
获取原文并翻译 | 示例

摘要

Pulmonary hypertension (PH) is characterized by an increase in blood pressure in the pulmonary vasculature associated with excessive vasoconstriction of pulmonary arteries and vascular remodeling. Pulmonary vasoconstriction is controlled by endogenous mediators, including those that act by stimulating G protein-coupled receptors (GPCRs). Vasoconstrictors such as serotonin (5-HT), endothelin-1 (ET-1) and thromboxane signal via GPCRs coupled to the G protein Gq. Gq activates signaling cascades in vascular smooth muscle that cause vasoconstriction. Regulators of G Protein Signaling 2 (RGS2) proteins turn off Gq signaling and thus inhibit the downstream pathways that cause vasoconstriction. Inhibition of RGS2 increases Gq-coupled GPCR vasoconstriction caused by many endogenous vasoconstrictors, including those implicated in PH.;Hypoxia is a key factor in the development of PH. Acute hypoxia causes hypoxic pulmonary vasoconstriction (HPV), which regulates ventilation by diverting blood flow away from poorly oxygenated regions of the lung. HPV is associated with an increase in calcium (Ca2+) mobilization, initially due to Ca2+ release from intracellular stores and followed by a sustained increase in Ca2+ influx through voltage-gated Ca2+ channels. Chronic hypoxia causes PH, in part, by enhanced Ca2+ mobilization contributing to HPV. Thus I hypothesized that hypoxia reduces RGS2 in pulmonary arteries, causing increased calcium mobilization and excessive vasoconstriction that may contribute to the development of PH. My objectives were:;1. To characterize the effects of RGS2 on Gq-coupled GPCR agonistmediated constriction and Ca2+ signaling in human pulmonary arterial smooth muscle (HPASM) cells. RGS2 protein was knocked-down (KD) in HPASM cells using RGS2 siRNA. I measured Gq-coupled GPCRmediated Ca2+ mobilization and contraction in RGS2 KD and scrambled HPASM cells.;2. To determine the effects of RGS2 on mouse pulmonary artery vasoconstriction activated by Gq-coupled GPCR agonists. I prepared precision cut lung slices (lung slices) from RGS2 KO and WT mice and assessed Gq-coupled GPCR agonist-mediated constriction concentrationresponse curves.;3. To determine the effects of hypoxia on mouse pulmonary artery vasoconstriction activated by Gq-coupled GPCR agonists. RGS2 KO and WT lung slices were incubated in hypoxia for 48 h and concentrationresponse curves for 5-HT and U46619 (thromboxane A2 mimetic) were analyzed.;4. To determine whether hypoxia enhancement of Gq-coupled GPCR agonist-mediated Ca2+ signaling and pulmonary arterial constriction is caused by down-regulation of RGS2 expression, HPASM cells were incubated in hypoxia (1% O2) or normoxia (21% O2) for 1-48 h and RGS2 expression was measured by western blotting. HPASM cells were also cultured for 48 h in hypoxia and Ca2+ mobilization and contraction of HPASM cells measured. Additionally, I incubated RGS2 KD HPASM cells in hypoxia and measured RGS2 expression along with Ca 2+ mobilization and contraction.;5. To determine whether RGS2 KO mice develop right ventricular hypertrophy. I measured the heart wt /body wt (HW/BW) and Fulton Index of RGS2 KO and WT mice.;U46619- and ET-1-mediated Ca2+ mobilization and contraction were significantly increased in RGS2 KD HPASM cells compared to scrambled control cells. Pulmonary arteries from RGS2 KO lung slices also exhibited enhanced constriction induced by 5-HT and U46619 compared to WT mice. Hypoxia enhanced the Ca2+ mobilization and contraction induced by U46619 and ET-1 in HPASM cells. Hypoxia did not significantly down-regulate RGS2 expression in RGS2 KD HPASM cells but did increase the Ca2+ mobilization and contraction of RGS2 KD HPASM cells. Hypoxia enhanced the pulmonary arterial constriction of WT mouse lung slices; however, it did not increase constriction of RGS2 KO lung slices. HW/BW and Fulton Index were significantly increased in RGS2 KO mice in comparison to WT mice.;In conclusion, RGS2 plays a role in GPCR-mediated contraction and Ca 2+ mobilization of HPASM cells and mouse pulmonary arteries. Hypoxia downregulates RGS2, which is associated with augmented Ca2+ signaling and constriction that may contribute to the development of PH.
机译:肺动脉高压(PH)的特征是肺血管中的血压升高与肺动脉过度血管收缩和血管重塑有关。肺血管收缩受内源性介质控制,包括那些通过刺激G蛋白偶联受体(GPCR)起作用的介质。血管收缩剂,例如5-羟色胺(5-HT),内皮素-1(ET-1)和血栓烷信号通过与G蛋白Gq偶联的GPCR传递。 Gq激活血管平滑肌中引起血管收缩的信号级联反应。 G蛋白信号传导2(RGS2)调节剂会关闭Gq信号传导,从而抑制导致血管收缩的下游途径。抑制RGS2会增加由许多内源性血管收缩剂(包括与PH有关的内源性血管收缩剂)引起的Gq偶联GPCR血管收缩。低氧是PH发生的关键因素。急性缺氧会导致缺氧性肺血管收缩(HPV),它通过将血流从肺部含氧量低的区域转移开来调节通气。 HPV与钙(Ca2 +)动员的增加有关,最初是由于Ca2 +从细胞内储存中释放出来,然后是通过电压门控的Ca2 +通道持续增加的Ca2 +流入量。慢性缺氧会导致PH升高,部分原因是Ca2 +动员能力增强导致HPV。因此,我假设缺氧会降低肺动脉中的RGS2,从而引起钙动员的增加和过度的血管收缩,这可能有助于PH的发展。我的目标是:1.。表征RGS2对人肺动脉平滑肌(HPASM)细胞中Gq偶联GPCR激动剂介导的收缩和Ca2 +信号传导的影响。使用RGS2 siRNA在HPASM细胞中敲除RGS2蛋白。我测量了RGS2 KD和混杂的HPASM细胞中Gq偶联的GPCR介导的Ca2 +动员和收缩。; 2。要确定RGS2对Gq偶联GPCR激动剂激活的小鼠肺动脉血管收缩的作用。我从RGS2 KO和WT小鼠制备了精密切割的肺切片(肺切片),并评估了Gq偶联的GPCR激动剂介导的收缩浓度反应曲线。3。要确定缺氧对Gq偶联GPCR激动剂激活的小鼠肺动脉血管收缩的影响。将RGS2 KO和WT肺切片在缺氧条件下孵育48小时,并分析5-HT和U46619(血栓烷A2模拟物)的浓度响应曲线。为了确定Gq偶联GPCR激动剂介导的Ca2 +信号传导的低氧增强和肺动脉收缩是否是由RGS2表达的下调引起的,将HPASM细胞在低氧(1%O2)或常氧(21%O2)中温育1- 48小时,通过蛋白质印迹法测量RGS2表达。在缺氧条件下还将HPASM细胞培养48小时,并测量HPASM细胞的Ca2 +动员和收缩。另外,我在缺氧条件下孵育了RGS2 KD HPASM细胞,并测量了RGS2的表达以及Ca 2+的动员和收缩。5。为了确定RGS2 KO小鼠是否发展右心室肥大。我测量了RGS2 KO和WT小鼠的心脏wt / body wt(HW / BW)和Fulton指数。与扰乱的对照细胞相比,RGS2 KD HPASM细胞中U46619和ET-1介导的Ca2 +动员和收缩显着增加。与野生型小鼠相比,来自RGS2 KO肺切片的肺动脉也表现出5-HT和U46619诱导的增强收缩。低氧增强了HPASM细胞中U46619和ET-1诱导的Ca2 +动员和收缩。缺氧不会显着下调RGS2 KD HPASM细胞中RGS2的表达,但会增加Ca2 +动员和RGS2 KD HPASM细胞的收缩。低氧增强了野生型小鼠肺片的肺动脉收缩;但是,它并没有增加RGS2 KO肺切片的收缩。与WT小鼠相比,RGS2 KO小鼠的HW / BW和Fulton指数显着增加。总之,RGS2在GPCR介导的HPASM细胞和小鼠肺动脉收缩和Ca 2+动员中起作用。缺氧下调RGS2,这与可能会促进PH发生的Ca2 +信号传导增加和收缩相关。

著录项

  • 作者

    Jain, Neha.;

  • 作者单位

    Creighton University.;

  • 授予单位 Creighton University.;
  • 学科 Pharmacology.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 204 p.
  • 总页数 204
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号